2015 Q3/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +4 Anika Therapeutics
7.8
2 +0 Neurocrine Biosciences
7.6
3 +10 Wockhardt
7.4
4 -3 Actelion
7.2
5 -1 Kyorin Holdings
7.0
6 +3 Taisho Pharmaceutical
7.0
7 +11 Yakult UK
6.9
8 -6 Otsuka Pharmaceuticals Europe
6.9
9 -6 Nissan Chemical
6.8
10 -4 Kaken Pharmaceutical
6.7
11 -4 ProStrakan Group
6.4
12 -4 Meda Pharmaceuticals
6.4
13 +10 Mitsubishi Tanabe Pharma Europe Ltd
6.3
14 -4 Galenica AG
6.2
15 +0 Diffusion Pharmaceuticals
6.1
16 -2 Bavarian Nordic
6.0
17 +10 Debiopharm
5.9
18 +11 Dainippon Sumitomo
5.9
19 +9 Zandu
5.8
20 -8 Lundbeck
5.7
21 +13 Forest
5.6
22 -3 Medivation
5.5
23 -2 EISAI
5.4
24 +32 Alfa Wassermann
5.4
25 +23 Pfizer UK
5.3
26 -4 EISAI UK
5.3
27 -10 Servier
5.2
28 +35 Astellas Europe
5.2
29 -4 United Therapeutics
5.2
30 -4 Santen
5.2
31 +0 Takeda UK
5.1
32 -2 Gruenenthal
5.1
33 -22 Ipsen UK
5.1
34 -14 Recordati
5.1
35 +8 Enzo Biochem
5.0
36 +31 Genmab
5.0
37 +12 Stallergenes UK
5.0
38 +150 Dr Reddy's
5.0
39 -15 CinnaGen
5.0
40 +4 Covence
4.9
41 -10 Towa Pharmaceutical
4.9
42 -9 Astrazeneca Uk
4.9
43 -8 Valeant Europe
4.9
44 +16 Acorda Therapeutics
4.9
45 +27 BTG International
4.9
46 -10 Daiichi-Sankyo UK
4.9
47 +5 Shire
4.9
48 +10 Stallergenes
4.9
49 -9 Agennix
4.8
50 -9 MediGene
4.8


Changes in rank are compared to 2015 Q2/Global Life Sciences. Since then, 9 sites entered the survey, 4 sites left the survey and 41 sites could not be included in the rankings (7 fewer since last time). Build your own. Report statistics.